M. Shimabukuro

Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial

K. Kario, M. Matsuhisa, K. Node, 2022, European heart journal. Cardiovascular pharmacotherapy.

Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial

K. Node, N. Takahashi, S. Hiramitsu, 2022, Diabetes, obesity & metabolism.

Validation and modification of the AFHCHDC7 risk score for predicting the long-term cardiovascular disease risk after the Great East Japan earthquake: The Fukushima health management survey

S. Yasumura, H. Yabe, I. Miura, 2023, International Journal of Disaster Risk Reduction.

Development of a Japanese Healthy Diet Index: The Fukushima Health Management Survey 2011

M. Hosoya, S. Yasumura, E. Ma, 2022, International journal of environmental research and public health.

Association between Serum Inorganic Phosphorus Levels and Adverse Outcomes in Chronic Kidney Disease: The Fukushima CKD Cohort Study

Shuhei Watanabe, J. Kazama, K. Asahi, 2021, Internal medicine.

MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker

Michio Shimabukuro, M. Shimabukuro, 2023, Journal of atherosclerosis and thrombosis.

Dietary Patterns and New-Onset Type 2 Diabetes Mellitus in Evacuees after the Great East Japan Earthquake: A 7-Year Longitudinal Analysis in the Fukushima Health Management Survey

S. Yasumura, E. Ma, H. Yabe, 2022, Nutrients.